高脂血症通过ROS/Wnt/β-catenin通路损害钛种植体骨结合
本研究探讨高脂血症对钛种植体骨结合的影响及机制。在饮食诱导或基因型高脂血症小鼠股骨植入专用钛种植体,并在高脂培养基中培养原代小鼠成骨细胞。结果显示高脂血症导致两类小鼠骨结合不良,高脂培养基损害成骨分化,并引起ROS过度产生和Wnt/β-catenin通路抑制。
要点
- 高脂血症在饮食诱导和基因型小鼠中均导致钛种植体骨结合不良。
- 高脂环境通过ROS过度产生和Wnt/β-catenin通路抑制损害成骨细胞成骨分化。
- NAC或Wnt3a可减轻高脂条件下成骨细胞成骨能力下降,NAC可重新激活Wnt/β-catenin通路。
核心结论
- 高脂血症通过ROS/Wnt/β-catenin通路损害钛种植体骨结合。
- ROS或Wnt/β-catenin通路可作为改善高脂血症患者种植体骨结合的潜在治疗靶点。
研究设计与样本
- 体内实验在饮食诱导或基因型高脂血症小鼠股骨植入专用钛种植体。
- 体外实验在高脂培养基中于钛表面培养原代小鼠成骨细胞。
主要发现
- 高脂血症导致两类小鼠体内骨结合不良。
- 高脂培养基损害钛表面原代成骨细胞的成骨分化。
- 高脂培养基引起成骨细胞ROS显著过度产生并抑制Wnt/β-catenin通路。
- NAC和Wnt3a均减轻成骨细胞成骨能力下降。
- NAC在高脂刺激下重新激活成骨细胞Wnt/β-catenin通路。
临床怎么用
- 对高脂血症患者进行种植治疗时,可关注ROS或Wnt/β-catenin通路作为改善骨结合的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The influence of hyperlipidemia on titanium implant osseointegration and the underlying mechanisms is not well understood. This study investigates the changes in osseointegration and explores the potential mechanisms in hyperlipidemia conditions. In vivo, specialized titanium implants were implanted in the femurs of diet-induced or genetic hyperlipidemia mice. In vitro, primary murine osteoblasts were cultured on the titanium surface in high-fat medium. Results showed that hyperlipidemia led to poor osseointegration in both types of mice in vivo, and high-fat medium impaired the osteogenic differentiation of primary osteoblasts on the titanium surface in vitro. In addition, high-fat medium caused significant overproduction of reactive oxygen species (ROS) and inhibition of the Wnt/β-catenin pathway in osteoblasts. Both N-acetyl-L-cysteine (NAC, an ROS antagonist) and Wnt3a (an activator of the Wnt/β-catenin pathway) attenuated the poor osteogenic ability of osteoblasts. In addition, NAC reactivated the Wnt/β-catenin pathway in osteoblasts under high-fat stimulation. These results demonstrate that hyperlipidemia impairs osseointegration via the ROS/Wnt/β-catenin pathway and provide support for the ROS or Wnt/β-catenin pathway as a promising therapeutic target for the development of novel drugs or implant materials to improve the osseointegration of implants in hyperlipidemic patients.
引用
- Wang YN, Jia TT, Feng Y, et al. Hyperlipidemia Impairs Osseointegration via the ROS/Wnt/β-Catenin Pathway. J Dent Res. 2021. PMID: 33402029. doi:10.1177/0022034520983245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。